Pulse high volume hemofiltration

International Journal of Artificial Organs

Volumn 27, Issue 5, 2004, Pages 398-403

  Brendolan, A ^a   D'Intini, V ^a   Ricci, Z ^a   Bonello, M ^a   Ratanarat, R ^a   Salvadori, G ^a   Bordoni, V ^a   De Cal, M ^a   Andrikos, E ^a   Ronco, Claudio ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Cytokine removal; High volume hemofiltration; Sepsis

Indexed keywords

CRITICALLY ILLS; CYTOKINE REMOVAL; CYTOKINES; HEMOFILTRATION; HIGH VOLUME HEMOFILTRATION; HIGH VOLUMES; HOMOEOSTASIS; INFLAMMATORY MEDIATORS; RENAL FAILURE; SEPSIS;

ACTIVATED PROTEIN C; HYPERTENSIVE AGENT; INSULIN; MIDAZOLAM; MORPHINE; NORADRENALIN; SUFENTANIL;

ACUTE KIDNEY FAILURE; ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; CRITICAL ILLNESS; DOSE RESPONSE; EXTRACORPOREAL CIRCULATION; FEASIBILITY STUDY; HEMODIALYSIS; HEMODYNAMICS; HEMOFILTRATION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PURIFICATION; RELIABILITY; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; ULTRAFILTRATION;

EID: 3042529873     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402700508     Document Type: Article

References (24)

1. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-91.
2. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-50.
3. Tetta C, De Nitti CM, Wratten ML, et al. Do circulating cytokines really matter in sepsis? Kidney Int 203; (suppl) 84: S69-71.
4. Pinsky MR. Sepsis: A pro- and anti-inflammatory disequilibrium syndrome. Contrib Nephrol 2001; 132: 354-66.
5. Cavaillon JM, Adib-Conquy M, Cloez-Tayarani I, Fitting C. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: A review. J Endotoxin Res 2001; 7: 85-93.
6. Volk HD, Reinke P, Krausch D, et al. Monocyte deactivation: rationale for a new therapeutic strategy in sepsis. Intensive Care Med 1996; (suppl) 4: S474-1.
7. Ronco C, Ricci Z, Bellomo R. Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role of continuous veno-venous hemofiltration. Curr Opin Nephrol Hypertens 2001; 10: 755-61.
8. Grootendorst AF, van Bommel EFH, van der Hoven B, van Leengoed LAM, van Osta ALM. High volume hemofiltration improves right ventricular function of endotoxin-induced shock in the pig. Intensive Care Med 1992; 18: 235-40.
9. Grootendorst AF, van Bommel EFH, van der Hoven B, et al. High volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. J Crit Care 1992; 7: 67-75.
10. Grootendorst AF, van Bommel EFH, van Leengoed LAM, et al. High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 1994; 2: 72-8.
11. Grootendorst AF, van Bommel EF, van Leengoed LA, et al. Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 1993; 8: 161-9.
12. Nagashima M, Shin'oka T, Nollert G, et al. High-volume continuous hemofiltration during cardiopulmonary bypass attenuates pulmonary dysfunction in neonatal lambs after deep hypothermic circulatory arrest. Circulation 1998; 98 (suppl 19): S378-84.
13. Lee PA, Matson JR, Pryor RW, Hinshaw LB. Continuous arteriovenous hemofiltration therapy for staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 1993; 21: 914-4.
14. Rogiers P, Zhang H, Smail N, et al. Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 1999; 27: 1848-55.
15. Yakebas EF, Eisenberger CF, Ohnesorge et al. Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 2001; 29: 1423-30.
16. Nagashima M, Shin'oka T, Nollert G, et al. High volume continuous hemofiltration during cardiopulmonary bypass attenuates pulmonary dysfunction in neonatal lambs after deep hypothermic circulatory arrest. Circulation 1998; 98 (suppl 19): S378-84.
17. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000; 356: 26-30.
18. Oudemans-van Straaten HM, Bosman RJ, et al. Outcome of critically ill patients treated with intermittent high-volume hemofiltration: A prospective cohort analysis. Intensive Care Med 1999; 25: 814-21.
19. Cole L, Bellomo R, Journois D, et al. High-volume hemofiltration in human septic shock. Intensive Care Med 2001; 27: 978-86.
20. Honore PM, Jamez J, Wauthier M, et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltrati6n on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000; 28: 3581-7.
21. Jamal JA, Hoh J, Bastani B. Removal of morphine with the high-efficiency and high-flux membranes during hemofiltration and heamodifiltration. Nephrol Dial Transplant 1998; 13: 1535-7.
22. Rivers L, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 145: 1368-77.
23. Wan L, Bellomo R, Di Giantomasso D, Ronco C. The pathogenesis of septic acute renal failure. Curr Opin Crit Care 2003; 9: 496-502.
24. D'Intini V, Bordoni V, Bolgan I, et al. Monocyte apoptosis in uremia is normalized with continuous blood purification modalites. Blood Purif 2004; 22: 9-12.